Category Archives: Uncategorized

Trial underway to study safety of retinal gene therapy for dry AMD

Last week, an 80-year-old Oxford woman became the first person to receive an experimental retinal gene therapy for dry AMD. Source: AAO

Posted on: Feb 26 2019
By: Saratoga Opthalmology
Leave a response

Exfoliation syndrome linked to increased risk of COPD

In this study, investigators evaluated the potential association between exfoliation syndrome and chronic obstructive pulmonary disease (COPD). Source: AAO

Posted on: Feb 25 2019
By: Saratoga Opthalmology
Leave a response

Characteristics of optic neuropathy in patients with Behçet disease

This paper details the clinical characteristics of 25 patients with optic neuropathy from Behçet disease. Source: AAO

Posted on: Feb 22 2019
By: Saratoga Opthalmology
Leave a response

Week in review: Smoke damage, prion precautions, FDA heyday

This week, heavy smoking damages color vision and contrast sensitivity, donor corneas and ophthalmology instruments could transmit prions and the FDA has been busy approving eye-related devices and treatments. Source: AAO

Posted on: Feb 22 2019
By: Saratoga Opthalmology
Leave a response

Adverse events caused by nivolumab and ipilimumab can be sight-threatening

This is the largest case series assessing ocular immune-related adverse events (IRAE) in patients treated with immunotherapy agents nivolumab and ipilimumab. Source: AAO

Posted on: Feb 21 2019
By: Saratoga Opthalmology
Leave a response

Promising refractive, visual outcomes 3 months after SMILE for pediatric hyperopia

This study evaluated the visual and refractive outcomes of small incision lenticule extraction (SMILE) for hyperopia in children. Source: AAO

Posted on: Feb 20 2019
By: Saratoga Opthalmology
Leave a response

Statin therapy may stave off vision-threatening diabetic retinopathy

This study evaluates the association between statin therapy and the development of diabetic retinopathy in patients with type 2 diabetes and dyslipidemia. Source: AAO

Posted on: Feb 19 2019
By: Saratoga Opthalmology
Leave a response

Xeroderma pigmentosum linked to high incidence of eyelid and ocular surface malignancies

This retrospective study reports the incidence, treatment and outcomes of ocular and periocular tumors in cases of xeroderma pigmentosum (XP). Source: AAO

Posted on: Feb 18 2019
By: Saratoga Opthalmology
Leave a response

Week in review: Cannabis drops, TearCare touchup, not-so-smart phones

This week, a cannabis-based eyedrop for glaucoma is poised for first-in-human trials, reapplying a TearCare treatment prolongs relief for patients with dry eye and uncalibrated smart phones raise the risk of misdiagnosing eye conditions. Source: AAO